RIFAXIMIN for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 99 adverse event reports in the FDA FAERS database where RIFAXIMIN was used for Off label use.
Most Reported Side Effects for RIFAXIMIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 3,687 | 26.6% | 3,682 | 303 |
| Hospitalisation | 1,605 | 11.6% | 198 | 1,602 |
| Therapy interrupted | 875 | 6.3% | 162 | 563 |
| Off label use | 802 | 5.8% | 46 | 115 |
| Diarrhoea | 709 | 5.1% | 46 | 167 |
| Ammonia increased | 676 | 4.9% | 90 | 564 |
| Inability to afford medication | 672 | 4.9% | 89 | 396 |
| Insurance issue | 577 | 4.2% | 88 | 336 |
| Confusional state | 530 | 3.8% | 53 | 344 |
| Hepatic cirrhosis | 480 | 3.5% | 305 | 224 |
| Hepatic encephalopathy | 462 | 3.3% | 93 | 347 |
| Product use in unapproved indication | 439 | 3.2% | 21 | 57 |
| Drug ineffective | 436 | 3.2% | 68 | 148 |
| Fall | 433 | 3.1% | 81 | 322 |
| Product use issue | 421 | 3.0% | 91 | 258 |
Other Indications for RIFAXIMIN
Product used for unknown indication (6,357)
Hepatic encephalopathy (2,587)
Hepatic cirrhosis (1,346)
Irritable bowel syndrome (964)
Gastrointestinal bacterial overgrowth (626)
Product use in unapproved indication (421)
Liver disorder (384)
Hepatic failure (361)
Diarrhoea (210)
Ammonia increased (156)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)